242 related articles for article (PubMed ID: 18382056)
1. [Expression of Ki-67, Bcl-2,Bax and caspase-3 in benign prostatic hyperplasia combined with prostatitis and their significances].
Wang L; Yang JR; Yang LY; Liu ZT; Rao JM; Liu LF
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):222-6. PubMed ID: 18382056
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma.
Iacopino F; Angelucci C; Lama G; Zelano G; La Torre G; D'Addessi A; Giovannini C; Bertaccini A; Macaluso MP; Martorana G; Sica G
Anticancer Res; 2006; 26(3A):1849-54. PubMed ID: 16827116
[TBL] [Abstract][Full Text] [Related]
3. Resistance to apoptosis and up regulation of Bcl-2 in benign prostatic hyperplasia after androgen deprivation.
Cardillo M; Berchem G; Tarkington MA; Krajewski S; Krajewski M; Reed JC; Tehan T; Ortega L; Lage J; Gelmann EP
J Urol; 1997 Jul; 158(1):212-6. PubMed ID: 9186362
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis profiles in benign prostatic hyperplasia: close associations of cell kinetics with percent area density of histologic composition.
Zhang X; Zhang Q; Zhang Z; Na Y; Guo Y
Urology; 2006 Oct; 68(4):905-10. PubMed ID: 17070390
[TBL] [Abstract][Full Text] [Related]
5. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium.
Wang W; Bergh A; Damber JE
Prostate; 2004 Sep; 61(1):60-72. PubMed ID: 15287094
[TBL] [Abstract][Full Text] [Related]
6. Reverse transcriptase-PCR analysis of apoptosis-regulating gene expression in human benign prostatic hyperplasia.
Angelucci C; Iacopino F; Lama G; Zelano G; Gianesini G; Sica G; Bono AV
Anticancer Res; 2005; 25(6B):3937-41. PubMed ID: 16309180
[TBL] [Abstract][Full Text] [Related]
7. Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis.
Salakou S; Kardamakis D; Tsamandas AC; Zolota V; Apostolakis E; Tzelepi V; Papathanasopoulos P; Bonikos DS; Papapetropoulos T; Petsas T; Dougenis D
In Vivo; 2007; 21(1):123-32. PubMed ID: 17354625
[TBL] [Abstract][Full Text] [Related]
8. Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.
Shariat SF; Ashfaq R; Roehrborn CG; Slawin KM; Lotan Y
J Urol; 2005 Nov; 174(5):2046-50. PubMed ID: 16217391
[TBL] [Abstract][Full Text] [Related]
9. [Expression of estrogen receptor beta in benign prostatic hyperplasia complicated by chronic prostatitis].
Yang GQ; Li SW; Zheng H; Zhang WB; Hu WL; Zheng XM
Zhonghua Nan Ke Xue; 2009 Apr; 15(4):314-7. PubMed ID: 19472903
[TBL] [Abstract][Full Text] [Related]
10. Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of bcl-2 in areas of inflammation.
Gerstenbluth RE; Seftel AD; MacLennan GT; Rao RN; Corty EW; Ferguson K; Resnick MI
J Urol; 2002 May; 167(5):2267-70. PubMed ID: 11956490
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis in prostate cancer: bax correlation with stage.
Amirghofran Z; Monabati A; Gholijani N
Int J Urol; 2005 Apr; 12(4):340-5. PubMed ID: 15948719
[TBL] [Abstract][Full Text] [Related]
12. [Influence of androgen on Bcl-2 mRNA expression in BPH tissue].
Wang X; Ye H; Jiang H; Xu Q; Zhu J; Hou S
Zhonghua Wai Ke Za Zhi; 2000 Mar; 38(3):198-200. PubMed ID: 11832028
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
[TBL] [Abstract][Full Text] [Related]
14. Increased caspase-3 and altered expression of apoptosis-associated proteins, Bcl-2 and Bax in lichen planus.
Abdel-Latif AM; Abuel-Ela HA; El-Shourbagy SH
Clin Exp Dermatol; 2009 Apr; 34(3):390-5. PubMed ID: 19309373
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of Ki-67 antigen, cox-2 and Bax/Bcl-2 in prostate cancer; prognostic value in biopsies and radical prostatectomy specimens.
Rubio J; Ramos D; López-Guerrero JA; Iborra I; Collado A; Solsona E; Almenar S; Llombart-Bosch A
Eur Urol; 2005 Nov; 48(5):745-51. PubMed ID: 16139948
[TBL] [Abstract][Full Text] [Related]
16. Deregulation of tissue homeostasis in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.
Villavicencio A; Bacallao K; Gabler F; Fuentes A; Albornoz J; Casals A; Vega M
Gynecol Oncol; 2007 Feb; 104(2):290-5. PubMed ID: 17030058
[TBL] [Abstract][Full Text] [Related]
17. [Expressions of SIgA and alpha 1-AR in benign prostatic hyperplasia combined with chronic prostatitis and their implications].
Gao WJ; Wang YM; Wang CH; Yang XK; Wan L; Li WP
Zhonghua Nan Ke Xue; 2013 Apr; 19(4):315-20. PubMed ID: 23678709
[TBL] [Abstract][Full Text] [Related]
18. [Expressions of integrinalpha2beta1 and CD133 in benign prostatic hyperplasia complicated by prostatitis and their significance].
Ding Q; Miao WL; Liu S; Chang JW; Yang YM
Zhonghua Nan Ke Xue; 2011 Oct; 17(10):909-12. PubMed ID: 22049795
[TBL] [Abstract][Full Text] [Related]
19. [Protein expression of p53, bcl-2, and bax in adenoid cystic carcinoma of lacrimal gland].
You JQ; Wang P
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1978-82. PubMed ID: 19062739
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities of apoptotic and cell cycle regulatory proteins in distinct histopathologic components of benign prostatic hyperplasia.
Gandour-Edwards R; Mack PC; Devere-White RW; Gumerlock PH
Prostate Cancer Prostatic Dis; 2004; 7(4):321-6. PubMed ID: 15314639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]